IMAC Holdings, Inc. (BACK)
USD 1.1
(-5.17%)
USD 1.1
(-5.17%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -221.51 Thousand USD | -106.53% |
| 2022 | 3.39 Million USD | 379.39% |
| 2021 | -1.21 Million USD | -118.64% |
| 2020 | 6.51 Million USD | -18.66% |
| 2019 | 8 Million USD | 42.0% |
| 2018 | 5.63 Million USD | 792.27% |
| 2017 | 632.03 Thousand USD | 268.0% |
| 2016 | -376.2 Thousand USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -17.53 Thousand USD | 92.08% |
| 2023 Q3 | 897.69 Thousand USD | -51.14% |
| 2023 Q4 | -221.51 Thousand USD | -124.68% |
| 2023 FY | -221.51 Thousand USD | -106.53% |
| 2023 Q1 | 1.98 Million USD | -41.53% |
| 2023 Q2 | 1.83 Million USD | -7.38% |
| 2022 Q2 | 3.36 Million USD | 203.37% |
| 2022 FY | 3.39 Million USD | 379.39% |
| 2022 Q3 | 1.81 Million USD | -46.05% |
| 2022 Q1 | 1.1 Million USD | 191.33% |
| 2022 Q4 | 3.39 Million USD | 86.9% |
| 2021 Q3 | -4.49 Million USD | 22.91% |
| 2021 FY | -1.21 Million USD | -118.64% |
| 2021 Q1 | -8.07 Million USD | -224.03% |
| 2021 Q4 | -1.21 Million USD | 72.99% |
| 2021 Q2 | -5.83 Million USD | 27.81% |
| 2020 Q4 | 6.51 Million USD | -16.2% |
| 2020 Q2 | 7.52 Million USD | -6.03% |
| 2020 Q1 | 8 Million USD | -0.06% |
| 2020 FY | 6.51 Million USD | -18.66% |
| 2020 Q3 | 7.77 Million USD | 3.36% |
| 2019 Q3 | 8.29 Million USD | 33.2% |
| 2019 Q4 | 8 Million USD | -3.44% |
| 2019 Q2 | 6.22 Million USD | 20.77% |
| 2019 Q1 | 5.15 Million USD | -8.59% |
| 2019 FY | 8 Million USD | 42.0% |
| 2018 Q2 | 4.55 Million USD | 85.47% |
| 2018 FY | 5.63 Million USD | 792.27% |
| 2018 Q4 | 5.63 Million USD | 11.42% |
| 2018 Q3 | 5.06 Million USD | 11.12% |
| 2018 Q1 | 2.45 Million USD | 288.58% |
| 2017 Q4 | 632.03 Thousand USD | 0.0% |
| 2017 FY | 632.03 Thousand USD | 268.0% |
| 2016 FY | -376.2 Thousand USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 1.41 Billion USD | 100.016% |
| Addus HomeCare Corporation | 110.39 Million USD | 100.201% |
| AirSculpt Technologies, Inc. | 89.4 Million USD | 100.248% |
| Amedisys, Inc. | 341.35 Million USD | 100.065% |
| American Oncology Network, Inc. | 99.78 Million USD | 100.222% |
| Astrana Health, Inc. | 27.2 Million USD | 100.814% |
| Aveanna Healthcare Holdings Inc. | 1.45 Billion USD | 100.015% |
| biote Corp. | 25.86 Million USD | 100.856% |
| Cryo-Cell International, Inc. | 10.48 Million USD | 102.112% |
| Cross Country Healthcare, Inc. | -11.82 Million USD | 98.127% |
| COMPASS Pathways plc | -187.58 Million USD | 99.882% |
| DocGo Inc. | -12.78 Million USD | 98.268% |
| The Ensign Group, Inc. | 1.36 Billion USD | 100.016% |
| Healthcare Services Group, Inc. | -10.69 Million USD | 97.929% |
| InnovAge Holding Corp. | 56.08 Million USD | 100.395% |
| Assure Holdings Corp. | 14.68 Million USD | 101.509% |
| The Joint Corp. | -2.47 Million USD | 91.066% |
| LifeStance Health Group, Inc. | 432.21 Million USD | 100.051% |
| Mobile-health Network Solutions Class A Ordinary Shares | -6.05 Million USD | 96.339% |
| ModivCare Inc. | 1.13 Billion USD | 100.019% |
| NewGenIvf Group Limited | 278.44 Thousand USD | 179.552% |
| Novo Integrated Sciences, Inc. | 4.05 Million USD | 105.462% |
| Option Care Health, Inc. | 822.56 Million USD | 100.027% |
| P3 Health Partners Inc. | 83.7 Million USD | 100.265% |
| P3 Health Partners Inc. | 83.7 Million USD | 100.265% |
| The Pennant Group, Inc. | 323.57 Million USD | 100.068% |
| Surgery Partners, Inc. | 2.86 Billion USD | 100.008% |
| Syra Health Corp. Class A Common Stock | -3.03 Million USD | 92.694% |
| Talkspace, Inc. | -123.9 Million USD | 99.821% |
| Talkspace, Inc. | -123.9 Million USD | 99.821% |
| The Oncology Institute, Inc. | 86.32 Million USD | 100.257% |
| The Oncology Institute, Inc. | 86.32 Million USD | 100.257% |